INSTITUT CURIE tramitó un H2020: Signaling pathways are cascades of biochemical reactions that transduce environmental signals to the cell interior. The cells rely on the information transduced through signalling pathways to govern b...
2022-09-01 | Financiado

INSTITUT CURIE participó en un H2020: The aim of PROTECT-trial is to compare the clinical outcome of proton therapy (PT) and conventional radiotherapy in a randomized study and to use the data and experience to advance the field of eviden...
2021-07-01 | Financiado

INSTITUT CURIE tramitó un H2020: Membrane receptors control fundamental physiological processes in cells, and are major targets of medical drugs. The goal of this project is to investigate the nanoscale motion of the membrane recepto...
2021-04-01 | Financiado

INSTITUT CURIE participó en un FP7: The emergence of resistance to chemotherapy and targeted therapies is a major challenge for the treatment of cancer. While several genetic mechanisms driving resistance processes have been discovered,...
2021-01-01 | Financiado

INSTITUT CURIE participó en un H2020: Pre-clinical drug development for paediatric cancers is very complex, resource intensive and requiring multi-disciplinary expertise and innovative approaches. The VAGABOND ITN, consisting of 12 academ...
2020-12-01 | Financiado

INSTITUT CURIE tramitó un FP7: Mucosal associated invariant T cells (MAITs) represent an abundant subset in humans with unique specificity for microbial metabolites. MAIT conservation along evolution indicates important, non-redund...
2020-10-01 | Financiado

INSTITUT CURIE tramitó un H2020: Institut Curie proposes an innovative COFUND programme, EuReCa (Europe Research & Care) with the following aims: (1) to train a new generation of early-stage researchers (ESRs) able to achieve excelle...
2020-10-01 | Financiado

INSTITUT CURIE participó en un H2020: Personalised Medicine (PerMed) opens unexplored frontiers to treat diseases at the individual level combining clinical and omics information. However, the performances of the current simulation softwa...
2020-10-01 | Financiado

INSTITUT CURIE participó en un FP7: The interactions between tumor and its microenvironment are often critical to uncovering the mechanisms of tumor survival. A striking example is the recent success of immunotherapy approaches that exp...
2020-10-01 | Financiado

INSTITUT CURIE tramitó un H2020: The overarching objective of the proposed project is to find how and when organs asses their growth status and which mechanisms are deployed to ensure fine size adjustment during normal animal develop...
2020-06-01 | Financiado

INSTITUT CURIE tramitó un H2020: In order to adapt treatment to the multicity of cancer types, cancer patient management has been revolutionized in the past decades by personalized medicine. As part of this strategy, liquid biopsy ha...
2020-05-01 | Financiado

INSTITUT CURIE tramitó un H2020: Microbiota has a major impact on anti-tumor immune responses and efficacy of anticancer treatments. These effects are thought to be mediated by modulation of tumor-infiltrating myeloid cells. These in...
2020-04-01 | Financiado

INSTITUT CURIE tramitó un FP7: Reliable urinary test for the diagnosis of prostate cancer Prostate cancer is a life threatening disease which affects about 400,000 males and causes 92,000 deaths per year in Europe. Among suspected...
2020-02-01 | Financiado

INSTITUT CURIE participó en un H2020: OncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumours / lymphomas patients. The challenge will consist in prov...
2020-01-01 | Financiado

INSTITUT CURIE tramitó un H2020: Neurocristopathies caused by defects in the neural crest (NC) encompass a broad group of diseases from birth defects (cleftvpalate) to complex syndromes affecting systems such as heart, gut and adrena...
2019-11-01 | Financiado

INSTITUT CURIE participó en un H2020: Infectious diseases kill millions of people worldwide every year. Decades of research have revealed important insights into the molecular mechanisms pathogens employ to establish lasting infections, y...
2019-11-01 | Financiado

INSTITUT CURIE tramitó un H2020: RNA is an essential element in the flow of genetic information in the cell. Recent development of genome-wide techniques reveal multiple novel RNA transcripts, mostly non-coding (nc) for protein. Thei...
2019-09-01 | Financiado

INSTITUT CURIE participó en un H2020: Radiotherapy alone or in multimodality approaches is applied in 45-60% of all cancer patients, but despite technical innovations approximately only 50% are cured. Disease recurrence may be due to regr...
2019-09-01 | Financiado

INSTITUT CURIE tramitó un FP7: Glioblastoma (GBM) is one of the deadliest types of human cancer. Despite a very aggressive treatment regime – including resection of the tumor, radiation and chemotherapy – its estimated recurrence r...
2019-08-01 | Financiado

INSTITUT CURIE participó en un H2020: ARCH is a network of highly qualified experts in experimental hematology created to decipher the causal relationship between the physiological changes in the hematopoietic system during lifespan and t...
2019-06-01 | Financiado